RPESC-RPE-4W — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-01 in 2mo
ESTIMATED |
READOUT
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation
Phase 1/2 · Dry Age-related Macular Degeneration |
Luxa Biotechnology, LLC | RPESC-RPE-4W |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|